Codes / ICD10CM / B69.8

B69.8 Cysticercosis of other sites

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Cysticercosis of other sites

Summary

Cysticercosis of other sites is a parasitic infection caused by the larval stage of the pork tapeworm, Taenia solium. The condition occurs when ingested tapeworm eggs develop into cysts (larvae) in tissues outside the central nervous system or eye, such as muscles, subcutaneous tissues, or other organs. It is a manifestation of cysticercosis that can present with localized symptoms depending on cyst location and burden.

Causes

The infection is caused by the larval form of Taenia solium, which is acquired by ingesting eggs from contaminated food, water, or surfaces. The eggs hatch in the intestine, and larvae penetrate the intestinal wall to migrate to tissues, where they form cysts. Human-to-human transmission occurs via the fecal-oral route, often through poor sanitation or consumption of undercooked pork.

Risk Factors

  • Residence in or travel to areas with poor sanitation and high Taenia solium prevalence.
  • Consumption of undercooked pork or contaminated food/water.
  • Close contact with individuals carrying the adult tapeworm (e.g., household members).
  • Immunocompromised states that may alter disease progression.

Symptoms

  • Palpable or asymptomatic subcutaneous or muscle cysts.
  • Localized pain, swelling, or inflammation at the cyst site.
  • Functional impairment if cysts affect organs (e.g., respiratory or gastrointestinal symptoms).
  • Rarely, systemic symptoms if cyst burden is high.

Diagnosis

Diagnosis involves clinical evaluation, imaging (e.g., ultrasound, MRI, or CT) to identify cysts in affected tissues, and serological tests for Taenia solium antibodies. Tissue biopsy may be performed if imaging is inconclusive. History of exposure to endemic regions or contaminated sources supports diagnosis.

Treatment Options

Treatment may include antiparasitic medications (e.g., albendazole or praziquantel) to target cysts, along with corticosteroids to reduce inflammation. Surgical removal of cysts may be necessary for large, symptomatic, or accessible lesions. Management is tailored to cyst location, size, and patient symptoms.

Prognosis and Follow-Up

Prognosis is generally favorable with appropriate treatment, though outcomes depend on cyst location and burden. Follow-up may include imaging to monitor cyst resolution and symptom assessment. Recurrence is possible if reinfection occurs, emphasizing prevention of exposure.

Complications

  • Local tissue damage or scarring from cysts.
  • Secondary infection or inflammation at the cyst site.
  • Rarely, systemic spread if cysts rupture or burden is high.

Lifestyle & Prevention

  • Practice good hygiene, including handwashing and safe food preparation.
  • Avoid consumption of undercooked pork or contaminated water.
  • Ensure proper sanitation in endemic areas to reduce egg exposure.
  • Seek prompt treatment for tapeworm infection to prevent larval spread.

When to Seek Professional Help

Consult a healthcare provider if you experience unexplained lumps, pain, or swelling, especially after travel to endemic regions. Seek immediate care for severe symptoms, such as difficulty breathing or organ dysfunction, which may indicate complications.

Tips for Medical Coders

Use code B69.8 for cysticercosis affecting sites other than the central nervous system or eye. Document the specific anatomical location (e.g., muscle, subcutaneous tissue) and any associated symptoms or complications to support coding accuracy. Ensure differentiation from other parasitic infections or cystic conditions.

Book a walkthrough

B69.8 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.